Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

Maurizio Averna, Maciej Banach, Éric Bruckert, Heinz Drexel, Michel Farnier, Dan Gaiță, Paolo Magni, Winfried März, L. Masana, Alberto Mello e Silva, Željko Reiner, Emilio Ros, Michal Vráblík, Alberto Zambon, José Luis Zamorano, Jane K. Stock, Lâle Tokgözoğlu, Alberico L. Catapano